Literature DB >> 34607877

Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Letter.

Bryson W Katona1, Randall E Brand2, Marcia I Canto3, Amitabh Chak4, James J Farrell5, Fay Kastrinos6, Anil K Rustgi6, Elena M Stoffel7, Sapna Syngal8, Michael Goggins.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34607877      PMCID： PMC8500478          DOI： 10.1158/1940-6207.CAPR-21-0233

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN： 1940-6215


× No keyword cloud information.
  5 in total

1.  Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.

Authors:  Marcia Irene Canto; Jose Alejandro Almario; Richard D Schulick; Charles J Yeo; Alison Klein; Amanda Blackford; Eun Ji Shin; Abanti Sanyal; Gayane Yenokyan; Anne Marie Lennon; Ihab R Kamel; Elliot K Fishman; Christopher Wolfgang; Matthew Weiss; Ralph H Hruban; Michael Goggins
Journal:  Gastroenterology       Date:  2018-05-24       Impact factor: 22.682

2.  Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.

Authors:  Hans Vasen; Isaura Ibrahim; Carmen Guillen Ponce; Emily P Slater; Elvira Matthäi; Alfredo Carrato; Julie Earl; Kristin Robbers; Anneke M van Mil; Thomas Potjer; Bert A Bonsing; Wouter H de Vos Tot Nederveen Cappel; Wilma Bergman; Martin Wasser; Hans Morreau; Günter Klöppel; Christoph Schicker; Martin Steinkamp; Jens Figiel; Irene Esposito; Evelina Mocci; Enrique Vazquez-Sequeiros; Alfonso Sanjuanbenito; Maria Muñoz-Beltran; José Montans; Peter Langer; Volker Fendrich; Detlef K Bartsch
Journal:  J Clin Oncol       Date:  2016-04-25       Impact factor: 44.544

3.  Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.

Authors:  Amanda L Blackford; Marcia Irene Canto; Alison P Klein; Ralph H Hruban; Michael Goggins
Journal:  J Natl Cancer Inst       Date:  2020-11-01       Impact factor: 13.506

4.  Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.

Authors:  Michael Goggins; Kasper Alexander Overbeek; Randall Brand; Sapna Syngal; Marco Del Chiaro; Detlef K Bartsch; Claudio Bassi; Alfredo Carrato; James Farrell; Elliot K Fishman; Paul Fockens; Thomas M Gress; Jeanin E van Hooft; R H Hruban; Fay Kastrinos; Allison Klein; Anne Marie Lennon; Aimee Lucas; Walter Park; Anil Rustgi; Diane Simeone; Elena Stoffel; Hans F A Vasen; Djuna L Cahen; Marcia Irene Canto; Marco Bruno
Journal:  Gut       Date:  2019-10-31       Impact factor: 23.059

5.  Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?

Authors:  Katharine E Caldwell; Alexander P Conway; Chet W Hammill
Journal:  Cancer Prev Res (Phila)       Date:  2020-11-03
  5 in total
  2 in total

1.  Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Response.

Authors:  Katharine E Caldwell; Chet W Hammill
Journal:  Cancer Prev Res (Phila)       Date:  2021-10

2.  Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma.

Authors:  Zixuan Wu; Xuyan Huang; Minjie Cai; Peidong Huang; Zunhui Guan
Journal:  Aging (Albany NY)       Date:  2022-01-24       Impact factor: 5.682
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.